{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:45:47Z","timestamp":1774975547161,"version":"3.50.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,23]],"date-time":"2027-01-23T00:00:00Z","timestamp":1800662400000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5U01CA271887"],"award-info":[{"award-number":["5U01CA271887"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK062708"],"award-info":[{"award-number":["DK062708"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.gtc.2025.10.006","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:10:31Z","timestamp":1763165431000},"page":"203-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biomarkers for the Diagnosis of Cirrhosis and Cirrhosis-Related Complications"],"prefix":"10.1016","volume":"55","author":[{"given":"Thomas","family":"Hunold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajalakshmi","family":"Govalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neehar","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.gtc.2025.10.006_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2023.5997","article-title":"Diagnosis and management of cirrhosis and its complications: a review","volume":"329","author":"Tapper","year":"2023","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.gtc.2025.10.006_bib2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMra1610570","article-title":"Use of liver imaging and biopsy in clinical practice","volume":"377","author":"Tapper","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.gtc.2025.10.006_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.gtc.2025.10.006_bib4","series-title":"BEST (biomarkers, endpoints, and other tools) resource","year":"2016"},{"issue":"2","key":"10.1016\/j.gtc.2025.10.006_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/HEP.0000000000000843","article-title":"AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis","volume":"81","author":"Sterling","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2025.10.006_bib6","article-title":"The liver cirrhosis network cohort study: cirrhosis definition, study population, and endpoints","volume":"10","author":"Tapper","year":"2022","journal-title":"J Am Coll Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2025.10.006_bib7","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1440-1746.2010.06612.x","article-title":"Biomarkers of liver fibrosis","volume":"26","author":"Adams","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2025.10.006_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/HEP.0000000000000845","article-title":"AASLD practice guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis","volume":"81","author":"Sterling","year":"2025","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gtc.2025.10.006_bib9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00004836-200607000-00013","article-title":"APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C","volume":"40","author":"Snyder","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2025.10.006_bib10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gtc.2025.10.006_bib11","article-title":"FIB-4 and APRI for cirrhosis detection in a privately insured national cohort","volume":"6","author":"Parikh","year":"2024","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.gtc.2025.10.006_bib12","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/j.gastro.2023.06.013","article-title":"AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of Nonalcoholic Fatty liver disease: expert review","volume":"165","author":"Wattacheril","year":"2023","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2025.10.006_bib13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.gtc.2025.10.006_bib14","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/hepr.12647","article-title":"Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: a meta-analysis study","volume":"46","author":"Sun","year":"2016","journal-title":"Hepatol Res"},{"issue":"11","key":"10.1016\/j.gtc.2025.10.006_bib15","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.cgh.2021.12.034","article-title":"Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population","volume":"20","author":"Graupera","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gtc.2025.10.006_bib16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gtc.2025.10.006_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21520","article-title":"FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C","volume":"45","author":"Koda","year":"2007","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.gtc.2025.10.006_bib18","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/MEG.0b013e32830dfcb3","article-title":"King\u2019s score: an accurate marker of cirrhosis in chronic hepatitis C","volume":"21","author":"Cross","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2025.10.006_bib19","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jhep.2017.01.003","article-title":"A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis","volume":"66","author":"Boursier","year":"2017","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2025.10.006_bib20","doi-asserted-by":"crossref","first-page":"952","DOI":"10.5009\/gnl210391","article-title":"Accuracy of noninvasive scoring systems in assessing liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"16","author":"Han","year":"2022","journal-title":"Gut Liver"},{"issue":"2","key":"10.1016\/j.gtc.2025.10.006_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/jhep.2003.50319","article-title":"Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin","volume":"38","author":"Poynard","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gtc.2025.10.006_bib22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/hepr.13495","article-title":"Accuracy of the enhanced liver fibrosis test, and combination of the enhanced liver fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"50","author":"Inadomi","year":"2020","journal-title":"Hepatol Res"},{"issue":"3","key":"10.1016\/j.gtc.2025.10.006_bib23","doi-asserted-by":"crossref","first-page":"280.e9","DOI":"10.1016\/j.amjmed.2006.06.044","article-title":"Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients","volume":"120","author":"Zaman","year":"2007","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.gtc.2025.10.006_bib24","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1373\/clinchem.2005.048389","article-title":"Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection","volume":"51","author":"Adams","year":"2005","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.gtc.2025.10.006_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0399-8320(08)73991-5","article-title":"FibroTest-ActiTest as a non-invasive marker of liver fibrosis","volume":"32","author":"Halfon","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"issue":"3","key":"10.1016\/j.gtc.2025.10.006_bib26","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2023.04.031","article-title":"NIS2+\u2122, an optimisation of the blood-based biomarker NIS4\u00ae technology for the detection of at-risk NASH: a prospective derivation and validation study","volume":"79","author":"Harrison","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2025.10.006_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-230X-6-6","article-title":"Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Ratziu","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2025.10.006_bib28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/ajg.2014.21","article-title":"FibroTest\/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis","volume":"109","author":"Salkic","year":"2014","journal-title":"J Am Coll Gastroenterol"},{"issue":"7","key":"10.1016\/j.gtc.2025.10.006_bib29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/apt.17385","article-title":"Meta-analysis: enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases","volume":"57","author":"Hinkson","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.gtc.2025.10.006_bib30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cgh.2019.05.051","article-title":"Development and validation of hepamet fibrosis scoring system\u2013a simple, noninvasive test to identify patients with nonalcoholic fatty liver disease with advanced fibrosis","volume":"18","author":"Ampuero","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2025.10.006_bib31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.gtc.2025.10.006_bib32","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.cgh.2007.07.020","article-title":"Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis","volume":"5","author":"Talwalkar","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2025.10.006_bib33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.29179","article-title":"Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis","volume":"67","author":"Herrmann","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.gtc.2025.10.006_bib34","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/liv.12240","article-title":"Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis","volume":"33","author":"Bota","year":"2013","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.gtc.2025.10.006_bib35","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/apt.13196","article-title":"Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study","volume":"41","author":"Cui","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.gtc.2025.10.006_bib36","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.cgh.2017.10.037","article-title":"Association between obesity and discordance in fibrosis stage determination by magnetic resonance vs transient elastography in patients with nonalcoholic liver disease","volume":"16","author":"Caussy","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2025.10.006_bib37","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"152","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.gtc.2025.10.006_bib38","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1007\/s10620-020-06763-9","article-title":"Comparison of seven noninvasive models for predicting decompensation and hospitalization in patients with cirrhosis","volume":"66","author":"Hsu","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.gtc.2025.10.006_bib39","article-title":"ALBI grade: evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma","volume":"3","author":"Demirtas","year":"2021","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.gtc.2025.10.006_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000675","article-title":"A systematic review of noninvasive laboratory indices and elastography to predict hepatic decompensation","volume":"9","author":"Grady","year":"2025","journal-title":"Hepatol Commun"},{"issue":"2","key":"10.1016\/j.gtc.2025.10.006_bib41","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end\u2013stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.gtc.2025.10.006_bib42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/lt.20329","article-title":"Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone","volume":"11","author":"Ruf","year":"2005","journal-title":"Liver Transplant"},{"issue":"6","key":"10.1016\/j.gtc.2025.10.006_bib43","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"Meld 3.0: the model for end-stage liver disease updated for the modern era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2025.10.006_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2024.101062","article-title":"Enhanced liver fibrosis (ELF) score predicts hepatic decompensation and mortality","volume":"6","author":"Pearson","year":"2024","journal-title":"JHEP Reports"},{"issue":"4","key":"10.1016\/j.gtc.2025.10.006_bib45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","article-title":"Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality","volume":"74","author":"Costa","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2025.10.006_bib46","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00535-019-01656-9","article-title":"The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis","volume":"55","author":"Schwarzer","year":"2020","journal-title":"J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2025.10.006_bib47","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jhep.2016.07.003","article-title":"Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis","volume":"65","author":"Sol\u00e0","year":"2016","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.gtc.2025.10.006_bib48","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1097\/MEG.0000000000001224","article-title":"Transient elastography can stratify patients with child\u2013pugh A cirrhosis according to risk of early decompensation","volume":"30","author":"Dillon","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.gtc.2025.10.006_bib49","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/liv.12525","article-title":"Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis","volume":"34","author":"Wang","year":"2014","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.gtc.2025.10.006_bib50","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jhep.2011.01.051","article-title":"Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study","volume":"55","author":"Robic","year":"2011","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2025.10.006_bib51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/jpm12020239","article-title":"Long-term outcome of HBV-infected patients with clinically significant portal hypertension achieving viral suppression","volume":"12","author":"Jachs","year":"2022","journal-title":"J Personalized Med"},{"issue":"2","key":"10.1016\/j.gtc.2025.10.006_bib52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/hep.32151","article-title":"Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: a retrospective study","volume":"75","author":"Gidener","year":"2022","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.gtc.2025.10.006_bib53","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.cgh.2020.09.044","article-title":"Liver stiffness by magnetic resonance elastography predicts future cirrhosis, decompensation, and death in NAFLD","volume":"19","author":"Gidener","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gtc.2025.10.006_bib54","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jhep.2023.05.022","article-title":"Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis","volume":"79","author":"Ballester","year":"2023","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.gtc.2025.10.006_bib55","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000419","article-title":"Association between serum levels of neurofilament light chains and minimal hepatic encephalopathy in patients with liver cirrhosis","author":"Labenz","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"17","key":"10.1016\/j.gtc.2025.10.006_bib56","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.3748\/wjg.v22.i17.4397","article-title":"Clinical scenarios for the use of S100\u03b2 as a marker of hepatic encephalopathy","volume":"22","author":"Duarte-Rojo","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2025.10.006_bib57","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2018.08.008","article-title":"miRNAs in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"69","author":"Liu","year":"2018","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2025.10.006_bib58","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2016.03.011","article-title":"PNPLA3 gene in liver diseases","volume":"65","author":"Tr\u00e9po","year":"2016","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2025.10.006_bib59","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/hep.31238","article-title":"Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population","volume":"72","author":"Gellert-Kristensen","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.gtc.2025.10.006_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16103","article-title":"Integrating PNPLA3 into clinical risk prediction","volume":"45","author":"Chen","year":"2025","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.gtc.2025.10.006_bib61","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gtc.2025.10.006_bib62","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2022.01.023","article-title":"HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis","volume":"77","author":"Singal","year":"2022","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2025.10.006_bib63","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2025.10.006_bib64","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.31309","article-title":"Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis","volume":"73","author":"Wolf","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gtc.2025.10.006_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/apt.13841","article-title":"Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"45","author":"Simmons","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.gtc.2025.10.006_bib66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhep.2022.08.036","article-title":"Blood-based biomarkers for hepatocellular carcinoma screening: approaching the end of the ultrasound era?","volume":"78","author":"Parikh","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2025.10.006_bib67","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cgh.2021.02.024","article-title":"Patient preferences for hepatocellular carcinoma surveillance parameters","volume":"20","author":"Woolen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2025.10.006_bib68","first-page":"1097","article-title":"Value of HCC surveillance in a landscape of emerging surveillance options: perspectives of a multi-stakeholder modified Delphi panel","volume":"10","author":"Singal","year":"2024","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.gtc.2025.10.006_bib69","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000422","article-title":"Alpha-fetoprotein: past, present, and future","volume":"8","author":"Yeo","year":"2024","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.gtc.2025.10.006_bib70","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"\u03b1-fetoprotein, des-\u03b3 carboxyprothrombin, and lectin-bound \u03b1-fetoprotein in early hepatocellular carcinoma","volume":"137","author":"Marrero","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2025.10.006_bib71","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cgh.2022.01.047","article-title":"The performance of AFP, AFP-3, DCP as biomarkers for detection of hepatocellular carcinoma (HCC): a phase 3 biomarker study in the United States","volume":"21","author":"Tayob","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2025.10.006_bib72","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.gastro.2024.09.008","article-title":"A phase 3 biomarker validation of GALAD for the detection of hepatocellular carcinoma in cirrhosis","volume":"168","author":"Marsh","year":"2025","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2025.10.006_bib73","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.32185","article-title":"GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis","volume":"75","author":"Singal","year":"2022","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.gtc.2025.10.006_bib74","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000565","article-title":"National liver cancer screening trial (TRACER) study protocol","volume":"8","author":"Singal","year":"2024","journal-title":"Hepatol Commun"},{"issue":"2","key":"10.1016\/j.gtc.2025.10.006_bib75","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/HEP.0000000000000953","article-title":"HES V2. 0 outperforms GALAD for detection of HCC: a phase 3 biomarker study in the United States","volume":"81","author":"El-Serag","year":"2025","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.gtc.2025.10.006_bib76","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.14309\/ajg.0000000000002539","article-title":"Blood-Based biomarkers for HCC surveillance: ready for the Center stage?","volume":"119","author":"Singal","year":"2024","journal-title":"J Am Coll Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2025.10.006_bib77","article-title":"A prospective trial to evaluate the performance of the multitarget hepatocellular carcinoma blood test (mt-HBT) for screening at-risk patients: the Altus study","volume":"40","author":"John","year":"2022","journal-title":"Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.gtc.2025.10.006_bib78","article-title":"A prospective clinical trial to evaluate the performance of a multi-analyte blood test for early detection of hepatocellular carcinoma among at-risk patients with liver cirrhosis: the CLiMB study","volume":"41","author":"Roy","year":"2023","journal-title":"Am Soc Clin Oncol"},{"issue":"12","key":"10.1016\/j.gtc.2025.10.006_bib79","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.cgh.2020.08.065","article-title":"A novel blood-based panel of methylated DNA and protein markers for detection of early-stage hepatocellular carcinoma","volume":"19","author":"Chalasani","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2025.10.006_bib80","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.32692","article-title":"HCC EV ECG score: an extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma","volume":"77","author":"Sun","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gtc.2025.10.006_bib81","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1038\/s41467-020-18311-0","article-title":"Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring","volume":"11","author":"Sun","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.gtc.2025.10.006_bib82","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/2159-8290.CD-22-0659","article-title":"Detecting liver cancer using cell-free DNA fragmentomes","volume":"13","author":"Foda","year":"2023","journal-title":"Cancer Discov"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855325000834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855325000834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:30:59Z","timestamp":1773804659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855325000834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0889855325000834"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2025.10.006","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers for the Diagnosis of Cirrhosis and Cirrhosis-Related Complications","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2025.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}